Assessment of the effeCt of lIfestyle iNtervention plus water-soluble ciNnAMon extract On loweriNg blood glucose in pre-diabetics, a randomized, double-blind, multicenter, placebo controlled trial: Study protocol for a randomized controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Crawford, Paul ^a   Thai, Chuong ^b   Obholz, Joshua ^b   Schievenin, Jeffrey ^b   True, Mark ^c   Shah, Sachin A ^d   Hallgren, John ^e   Clark, Jill ^f   Sharon, Danny ^g  

^a Nellis Family Medicine Residency   (United States)

^b AIR FORCE RESEARCH LABORATORY   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF THE PACIFIC   (United States)

^e Air Force Weather Agency   (United States)

^f Nellis Clinical Investigation Program   (United States)

^g Adolos Strategic   (United States)

Author keywords

Cinnamon; Cinnamon extract; Cinnulin PF; Diabetes; Impaired glucose tolerance; Pre diabetes; Prevention; Protocol

Indexed keywords

CINNAMON EXTRACT; GLUCOSE; HEMOGLOBIN A1C; PLACEBO; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; CINNAMOMUM ZEYLANICUM; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; LIFESTYLE; PHYTOTHERAPY; PREDIABETIC STATE; RISK ASSESSMENT; SAMPLE SIZE;

BLOOD GLUCOSE; CINNAMOMUM ZEYLANICUM; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; HUMANS; LIFE STYLE; PHYTOTHERAPY; PLANT EXTRACTS; PREDIABETIC STATE; RISK ASSESSMENT; SAMPLE SIZE;

EID: 84955631230     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-1138-7     Document Type: Article

References (28)

1. WHO. Global status report on noncommunicable diseases 2014. 2014. p. 68.
2. Qin B, Polansky MM, Sato Y, Adeli K, Anderson RA. Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals. J Nutr Biochem. 2009;20(11):901-8. Epub 2008 Nov 6.
3. Rafehi H, Ververis K, Balcerczyk A, Ziemann M, Ooi J, Hu S, et al. Investigation of the biological properties of Cinnulin PF in the context of diabetes: mechanistic insights by genome-wide mRNA-Seq analysis. Pathobiol Aging Age Relat Dis. 2012;2. doi: 10.3402/pba.v2i0.11905.
4. Luo Q, Wang SM, Lu Q, Luo J, Cheng YX. Identification of compounds from the water soluble extract of Cinnamomum cassia barks and their inhibitory effects against high-glucose-induced mesangial cells. Molecules. 2013;18(9):10930-43.
5. Cao H, Graves DJ, Anderson RA. Cinnamon extract regulates glucose transporter and insulin-signaling gene expression in mouse adipocytes. Phytomedicine. 2010;17(13):1027-32. doi: 10.1016/j.phymed.2010.03.023.
6. Cheng DM, Kuhn P, Poulev A, Rojo LE, Lila MA, Raskin I. In vivo and in vitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol-enhanced food matrix. Food Chem. 2012;135(4):2994-3002. doi: 10.1016/j.foodchem.2012.06.117. Epub 2012 Jul 14.
7. Khan A, Khattak KN, Safdar M, Anderson RA, Ali Khan MM. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215-8.
8. Vanschoonbeek K, Thomassen BJW, Senden JM, Wodzig WKWH, van Loon LJC. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977-80.
9. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, et al. Effects of a cinnamon extract on plasma glucose, HBA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36:340-4.
10. Altschuler JA, Casella SJ, MacKenzie TA, Curtis KM. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care. 2007;30(4):813-6.
11. Blevins SM, Leyva MJ, Brown J, Wright J, Scofield RH, Aston CE. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care. 2007;30(9):2236-7. Epub 2007 Jun 11.
12. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. 2006;3:45-53.
13. Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008;31(1):41-3.
14. Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009;22(5):507-12.
15. Fairman KA, Curtiss FR. Call for comparative effectiveness research: lowering A1C with sitagliptin, saxagliptin, or cinnamon. J Manag Care Pharm. 2009;15(8):696-700.
16. Hasanzade F, Toliat M, Emami SA, Emamimoghaadam Z. The effect of cinnamon on glucose of type II diabetes patients. J Tradit Complement Med. 2013;3(3):171-4.
17. Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 2012;9:CD007170.
18. Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013;11(5):452-9. http://www.annfammed.org/content/11/5/452.long. Accessed 4 April 2015.
19. Akilen R, Pimlott Z, Tsiami A, Robinson N. Effect of short-term administration of cinnamon on blood pressure in patients with prediabetes and type 2 diabetes. Nutrition. 2013;29(10):1192-6. Epub 2013 Jul 16.
20. Fabian E, Töscher S, Elmadfa I, Pieber TR. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58(2):101-8. doi: 10.1159/000326765.
21. Manya K, Champion B, Dunning T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med. 2012;12:2. doi: 10.1186/1472-6882-12-2.
22. American Diabetes Association. Standards of medical care in diabetes-2015: summary of revisions. Diabetes Care. 2015;38 Suppl:S4.
23. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-91.
24. Glantz SA. Primer of biostatistics. McGraw-Hill, New York; 2002. p. 438-440.
25. Bonferroni AH, Šidák. Corrections for multiple comparisons. In: Salkind NJ, editor. Encyclopedia of measurement and statistics. Thousand Oaks, CA: Sage 2007.
26. Holm S. A simple sequential rejective multiple test procedure. Scand J Statistics. 1979;6:65-70.
27. World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. 2013. p. 55. http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf. Accessed 4 April 2015.
28. Medagama AB, Bandara R. The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective? Nutr J. 2014;13:102. doi: 10.1186/1475-2891-13-102.